Humanigen Inc (HGENQ)
0.0002
-0.01
(-97.01%)
USD |
OTCM |
Apr 26, 16:00
Humanigen Total Assets (Quarterly): 5.116M for March 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 5.116M |
| December 31, 2022 | 11.20M |
| September 30, 2022 | 25.97M |
| June 30, 2022 | 49.45M |
| March 31, 2022 | 71.32M |
| December 31, 2021 | 71.06M |
| September 30, 2021 | 77.94M |
| June 30, 2021 | 121.73M |
| March 31, 2021 | 98.85M |
| December 31, 2020 | 68.30M |
| September 30, 2020 | 92.14M |
| June 30, 2020 | 42.57M |
| March 31, 2020 | 0.432M |
| December 31, 2019 | 0.523M |
| September 30, 2019 | 0.594M |
| June 30, 2019 | 1.587M |
| March 31, 2019 | 0.73M |
| December 31, 2018 | 1.37M |
| September 30, 2018 | 2.613M |
| June 30, 2018 | 1.003M |
| March 31, 2018 | 2.509M |
| December 31, 2017 | 1.67M |
| September 30, 2017 | 2.567M |
| Date | Value |
|---|---|
| June 30, 2017 | 1.921M |
| March 31, 2017 | 6.03M |
| December 31, 2016 | 4.718M |
| September 30, 2016 | 4.933M |
| June 30, 2016 | 13.46M |
| March 31, 2016 | 8.493M |
| December 31, 2015 | 11.15M |
| September 30, 2015 | 16.74M |
| June 30, 2015 | 24.75M |
| March 31, 2015 | 31.95M |
| December 31, 2014 | 42.98M |
| September 30, 2014 | 51.11M |
| June 30, 2014 | 61.34M |
| March 31, 2014 | 66.58M |
| December 31, 2013 | 78.70M |
| September 30, 2013 | 57.94M |
| June 30, 2013 | 66.19M |
| March 31, 2013 | 79.22M |
| December 31, 2012 | 24.54M |
| September 30, 2012 | 28.28M |
| June 30, 2012 | 29.73M |
| December 31, 2011 | 19.35M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.432M
Minimum
Mar 2020
121.73M
Maximum
Jun 2021
46.17M
Average
46.01M
Median
Total Assets (Quarterly) Benchmarks
| Athersys Inc | 7.428M |
| Merck & Co Inc | 106.68B |
| MEI Pharma Inc | 78.54M |
| ContraFect Corp | 9.125M |
| Bristol-Myers Squibb Co | 99.03B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 54.84M |
| Shareholders Equity (Quarterly) | -49.72M |
| Current Ratio | 0.0943 |
| Net Debt Paydown Yield | 29.27% |